InvestorsHub Logo
icon url

tikotiko

03/29/21 6:32 PM

#155452 RE: daemon57 #155451

Straight from your article: “ It will be interesting to see if Brazil adopts both lenzilumab and leronlimab or selects one of the other. Based on the clinical trial result and the MOA leronlimab is the superior drug candidate and probably has less ties to United States pressure to keep it all for themselves.”
Enough said,...
Thank you!
icon url

BBalls-N-CowTown

03/29/21 10:34 PM

#155466 RE: daemon57 #155451

Excellent and scathing. Tomorrow Our therapeutic, superior to HGEN’ s will be on day #18 after formal application for EUA.

CDC need to get their thumb out of their ass and advocate for Leronlimab with the FDA. We have a stockpile.